ACTRN12610000070033已完成不适用
A randomized trial to compare efficacy and safety of cyclosporin-prednisone versus mycophenolate mofetil-prednisone, 3 months after renal transplantation.
Protocole Hospitalier de Recherche Clinique (PHRC)0 个研究点目标入组 108 人开始时间: 2006年3月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •1) First renal transplantation from a deceased donor under a triple drug regimen (cyclosporine + mycophenolate mofetil + prednisone)
- •2) No acute rejection episode during the first 3 months post graft (time of randomisation)
- •3) Patients who gave their informed consent and are able to understand the scope of the study
排除标准
- •1) Living donor, re-transplantation
- •2) Panel ractive antibodies > 30%
- •3) Serum creatinine > 2.5 mg/dl (222 umol/l)
- •4) Cyclosporine toxicity at the time of randomisation (3 months post graft)
- •5) Patients with generalized infection at the time of transplantation
- •6) Women in child-bearing age who do not plan to use efficient contraception
- •7) Age of donor > 65
研究者
相似试验
进行中（未招募）
不适用
A randomised trial comparing efficacy and safety after intensification with either insulin aspart once daily as add-on or changing to basal bolus treatment with insulin degludec and insulin aspart in subjects with type 2 diabetes previously treated with insulin degludec/insulin aspart twice dailyMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2012-003152-37-DEovo Nordisk A/S97
进行中（未招募）
1 期
A randomized trial comparing efficacy and safety of etanercept and methotrexate in giant cell arteritis (EFFECTA)Giant cell arteritisCTIS2023-506623-29-01Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy212
进行中（未招募）
不适用
A randomized study comparing the safety and efficacy of ranibizumab (Lucentis ®) to sham in patients with macular edema secondary to central retinal vein occlusion (CRVO). - ROCCMacular edema secondary to central retinal vein occlusion (CRVO)MedDRA version: 8.1Level: LLTClassification code 10054467Term: Macular edemaEUCTR2006-005468-25-NORetinaklinikken Aleris
招募中
不适用
A comparison of radioactive iodine therapy versus anti-thyroid drugs as initial treatment for Graves diseaseCTRI/2016/03/006728Department of Internal Medicine90
尚未招募
4 期
A study to compare the wound dressings in post cancer surgery woundCTRI/2023/05/052574Dr Amritha Prabha